Research Methodology: From Analysis to Literature Comparison

Created using ChatSlide

This research publication investigates the efficacy and safety of Asundexian in reducing stroke recurrence through Factor XI inhibition, as reported in a Phase 3 double-blind study across 37 countries involving 12,327 participants. The findings indicate a reduction in stroke events without a significant increase in major bleeding, supporting Asundexian as a promising preventative therapy. While results validate targeting XIa, some limitations were noted, including demographic imbalances and...